Editor’s Note: Today’s post comes from Mike Luce, co-founder of High Yield Insights, one of the cannabis industry’s first marketing and strategy firms. This is the second of his two-part series on the mysterious world–and spurious marketing–of CBD, a product I’m sure you’ve seen advertised and made available nearly everywhere.
Mike Luce, of High Yield Insights
If CBD is so popular, why don’t we know more about it? This post, the second in a two-part series, examines consumer perceptions and the not-always-aligned realities of CBD products on the market. For consumers seeking the many positive purported benefits of the suddenly fashionable cannabis compound, there’s little easily-accessible information. Worse yet, we may be witnessing an explosion of misunderstanding and misinformation as an epidemic of lung injuries continues across the US.
Poisoned by black market products, nearly a thousand people have fallen ill across the country. As of this writing, illegal e-cigarettes have been implicated in at least 14 deaths. In over forty states, people have been struck by severe lung injuries from vaping, often at frightening speed. While research is still underway to isolate the specific substance or substances responsible, many hold black market THC e-cigarettes responsible. Something changed in the composition of the oil used by many black marketeers to fill vaporizer cartridges. Initial evidence suggests contamination by fungicides and the misuse of thickening agents to disguise diluted product. (I wrote about the outbreak in mid-September.) Either as a direct result, or in some unknown interaction with tobacco e-cigarettes as well, vaping has been turned deadly.
Continue reading →
Editor’s Note: Today’s post comes from Mike Luce, co-founder of High Yield Insights, one of the cannabis industry’s first marketing and strategy firms. Here he presents the first in his two-part series on the mysterious world–and spurious marketing–of CBD, a product I’m sure you’ve seen advertised and made available nearly everywhere. His follow-up will run on Tuesday next week. Stay tuned!
Americans are consumed by fads in food, drink, and wellness. We swing from one subject of fascination to another: antioxidants, açai, resveratrol, fat free, healthy fats, active cultures, spiked seltzers, organic, biodynamic, anything free range, you name it.
Yet the latest fad to hit the USA Today-level is unique in post-WWII America. Interest in CBD, the three letters you see everywhere, has reached a fever pitch. This does necessarily set CBD apart from other fads in consumer goods, but hitting the mainstream radar so fast and so hard puts CBD in the upper echelon. The potential of CBD is largely unknown and the future scale of what’s starting to be known as the CBD industry is unpredictable. Consumers, including those using CBD today, poorly grasp the nature of CBD, lack any precise understanding of how CBD works and what it does, and express significant concerns about safety. Yet forecasts place the CBD market at $15-20 billion by 2025. Contrast those figures with the latest numbers by some household products, and CBD’s estimates truly pop:
Sales of CBD will net out close to $5 billion in 2019, a puny number in comparison. But the last industry on the list above can’t expect more than low single digit annual growth rate. To reach the market size forecasts, CBD will experience compound annual growth rates over 100 percent. That new users will drive that growth should be obvious.
Continue reading →
Editor’s Note: Today’s post comes from contributing editor Dr. David A. Guba, Jr., of Bard Early College in Baltimore. There have been a lot of discussions about CBD – the non-psychoactive component of cannabis – lately. See, for example, this recent article in the New York Times. Guba points out that France’s short-lived experience with CBD cafes shows how history is continuously repeating itself, especially in terms of drug policy, and that a better understanding of how nations have dealt with intoxicants in the past could prevent the same mistakes from being made over and over again.
In the early summer of 2018, nearly four dozen stores selling legal “cannabis light,” or products with cannabidiol (CBD), ranging from distillate cartridges and edibles to actual flower, opened across France. After the first of these stores, called Bestown, appeared in the city of Annœullin (Hauts-de-France) on 24 May, over 50 similar establishments opened their doors in Paris, Nantes, Grenoble, Marseilles, Caen, Reims, and Lyon. Pictures of lines queued around the block at the Parisian merchant “Cofyshop” made the rounds in the international press. Le Monde devoted nearly a dozen articles to its coverage of “cannabis fever” sweeping the hexagon. Then on 11 June the government officially declared the stores illegal, and police swept in and barred their doors.
A Bestown shop, which opened in Béthune, in northern France, in May 2018. From France 3.
In August, the Bestown shop in Le Havre had to close. Transcription of note: “Following a change in legislation, we are forced to withdraw from sale our CBD products. We apologize for the inconvenience.” From ACTU France.
Continue reading →